TOLERANCE INDUCTION TO CULTURED ISLET ALLOGRAFTS .2. THE STATUS OF ANTIDONOR REACTIVITY IN TOLERANT ANIMALS

被引:19
作者
COULOMBE, M [1 ]
GILL, RG [1 ]
机构
[1] UNIV COLORADO,HLTH SCI CTR,BARBARA DAVIS CTR CHILDHOOD DIABET,DENVER,CO 80262
关键词
D O I
10.1097/00007890-199404270-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine islet tissue cultured in 95% O-2 to eliminate/inactivate donor antigen-presenting cells can function indefinitely and induce a state of tolerance in nonimmunosuppressed, allogeneic recipients. Such cultured grafts represent a model of antigen presentation in which antigen (signal 1) is presented without the delivery of appropriate costimulatory activity (signal 2) necessary for T cell activation. As T cell inactivation has been proposed to result from this form of antigen presentation, we determined whether the tolerance generated in response to such cultured grafts was due to a passive (clonal deletion/inactivation) mechanism. We have shown that, although tolerant in vivo, animals bearing long-term cultured islet allografts are donorreactive in vitro as assessed by (1) CTL precursor frequency, (2) antidonor proliferative and cytotoxic responses, and (3) lymphokine production (IL-2, IL-3, TNF, and IFN-gamma). In addition, tolerance does not appear to be tissue (islet)-specific in that primed, donor-reactive T cells from tolerant animals react to islet cells in vitro and are capable of destroying donor-type islet grafts in vivo. Thus, the notion that ''signal 1'' antigen presentation, as represented by cultured islet allografts, leads to the clonal deletion or inactivation (anergy) of donor-reactive T cells is not supported by these results. Since this form of tolerance does not appear to be an intrinsic property of the donor-specific lymphocyte, these results are more consistent with a model of active regulatory tolerance in vivo.
引用
收藏
页码:1201 / 1207
页数:7
相关论文
共 46 条
[21]   TOLERANCE IN T-CELL-RECEPTOR TRANSGENIC MICE INVOLVES DELETION OF NONMATURE CD4+8+ THYMOCYTES [J].
KISIELOW, P ;
BLUTHMANN, H ;
STAERZ, UD ;
STEINMETZ, M ;
VONBOEHMER, H .
NATURE, 1988, 333 (6175) :742-746
[22]   IMMUNOBIOLOGY OF TISSUE-TRANSPLANTATION - A RETURN TO THE PASSENGER LEUKOCYTE CONCEPT [J].
LAFFERTY, KJ ;
PROWSE, SJ ;
SIMEONOVIC, CJ ;
WARREN, HS .
ANNUAL REVIEW OF IMMUNOLOGY, 1983, 1 :143-173
[23]   EVIDENCE THAT TOLERANCE TO CULTURED THYROID ALLOGRAFTS IS AN ACTIVE IMMUNOLOGICAL PROCESS - PROTECTION OF 3RD-PARTY GRAFTS BEARING NEW ANTIGENS WHEN ASSOCIATED WITH TOLEROGENIC ANTIGENS [J].
LAROSA, FG ;
SMILEK, D ;
TALMAGE, DW ;
LAFFERTY, KJ ;
BAULING, P ;
AMMONS, TJ .
TRANSPLANTATION, 1992, 53 (04) :903-913
[24]   DIABETES AND TOLERANCE IN TRANSGENIC MICE EXPRESSING CLASS-II MHC MOLECULES IN PANCREATIC BETA-CELLS [J].
LO, D ;
BURKLY, LC ;
WIDERA, G ;
COWING, C ;
FLAVELL, RA ;
PALMITER, RD ;
BRINSTER, RL .
CELL, 1988, 53 (01) :159-168
[25]   T-CELLS CAN DISTINGUISH BETWEEN ALLOGENEIC MAJOR HISTOCOMPATIBILITY COMPLEX PRODUCTS ON DIFFERENT CELL-TYPES [J].
MARRACK, P ;
KAPPLER, J .
NATURE, 1988, 332 (6167) :840-843
[26]  
MCCULLAGH P, 1990, IMMUNOLOGY, V71, P595
[27]  
MILLER J, 1990, J IMMUNOL, V144, P334
[28]   PERIPHERAL T-CELL TOLERANCE [J].
MILLER, JFAP ;
MORAHAN, G .
ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 :51-69
[29]  
MOHLER KM, 1987, J IMMUNOL, V139, P2211
[30]   EXPRESSION IN TRANSGENIC MICE OF CLASS-I HISTOCOMPATIBILITY ANTIGENS CONTROLLED BY THE METALLOTHIONEIN PROMOTER [J].
MORAHAN, G ;
BRENNAN, FE ;
BHATHAL, PS ;
ALLISON, J ;
COX, KO ;
MILLER, JFAP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3782-3786